Literature DB >> 23050254

Oxidative stress in alcoholic and viral hepatitis.

Dipankar Kundu1, Anindya Roy, Tridibeswar Mandal, Ujjwal Bandyopadhyay, Enakshi Ghosh, Debes Ray.   

Abstract

Entities:  

Year:  2012        PMID: 23050254      PMCID: PMC3456484          DOI: 10.4103/1947-2714.100993

Source DB:  PubMed          Journal:  N Am J Med Sci        ISSN: 1947-2714


× No keyword cloud information.
Sir, Oxidative stress occurs when oxidative stress-related molecules, generated exceed intacellular antioxidant defences.[1] The liver has a critical role in the metabolism, digestion, detoxification, and elimination of substances from the body. Liver disease generally present clinically as hepatocellular, cholestatic (obstructive), or mixed.[2] The liver diseases produce reactive oxygen species that are involved in the transcription and activation of a large series of cytokines and growth factors which, in turn, can contribute to further production of Reactive Oxgen Species ROS and Reactive Nitrogen Species, RNS, continuing the vicious cycle.[3] The extent of cellular damage is manifested by either an increase in the oxidation products or a decrease in the antioxidant levels or both. Hence by measuring the oxidative stress parameters, the extent of liver damage can be assessed. Alcoholic and viral hepatitis, both these forms of hepatitis lead to hepatic damage of varying intensity. Although a lot of information is available regarding the biochemical changes and oxidative stress parameters in alcohol-induced hepatitis and hepatitis B virus infection separately, but a comparative study, taking both the forms of hepatitis into consideration, is lacking. This study aims to reveal differences in the extent of oxidative stress caused by chemical and biological agents causing hepatitis. The study was conducted after obtaining usual permission from ethical committee and consent from subjects and controls were taken before commencing the study. The control group (Group 1) consisted of 100 normal, healthy individuals between the age group of 20–75 years from Kolkata. The second group consists of 100 clinically proven alcoholic hepatitis patients, aged between 20 and 75 years and the third group consisted of 100 clinically and serologically proven cases of hepatitis B patients admitted in hospital. Smokers, chronic drug users, pregnant, painters, and diabetes patients were excluded from the study. A total of 100 patients with clinically proven alcoholic hepatitis in the age group 20-75 years formed (Group 2). A total of 100 patients with clinically and serologically proven Hepatitis B infection (Group 3) were included in the study. About 5 ml of venous sample was taken from groups 1, 2 and 3 under aseptic precautions. Of the 5 ml of blood sample, 3 ml was collected in ethylenediaminetetraacetic acid (EDTA) containing vacutainer for analysis of oxidative stress parameters and 2 ml in plain vacutainer for analyzing liver enzymes. Blood sample from the EDTA containing vacutainer was centrifuged at 3000 rpm for 10 min and supernatant plasma was used for ascorbic acid estimation using 2,4-Dinitrophenyl hydrazine (DNPH). The buffy coat was discarded. The packed cells were suspended in equal volume of cold phosphate buffer saline and re-centrifuged. The supernatant was discarded. The washing of packed cells was repeated twice and the packed cells were used for analysis of glutathione (GSH) and malondialdehyde (MDA). The blood sample from plain vacutainers was centrifuged at 3000 rpm for 10 min; the serum was separated and was further used for analyzing liver enzymes. The oxidative stress parameters that were assayed included – erythrocyte GSH which was estimated by 5,5′-Di Thiobis 2-Nitrobenzoic Acid (DTNB) method.[4] MDA in erythrocyte was evaluated by measuring the thiobarbituric acid reacting substances (TBARs).[5] Plasma ascorbic acid was estimated by DNPH method.[6] Aspartate amino transferase (AST), alanine amino transferase (ALT), gamma glutamyl transferase (GGT), and alkaline phosphatase (ALP) were measured by using standard methods adapted in the clinical laboratory. The values of all parameters were statistically analyzed using Statistical Package for the Social Sciences developed by IBM Corporation, SPSS 15.0 software. A comparison of the mean values of oxidative stress parameters and liver enzymes were done separately between groups 1and 2, groups 1 and 3, and groups 2 and 3 using independent t test. Pearson correlation was done to compare the oxidative stress parameters with liver enzymes. The mean values of GSH and MDA of groups 2 and 3 patients were found to be significant (P < 0.005) and different from that of group 1, but the difference was not significant. For ascorbic acid, the mean value of group 2 patients was found to be significant (P < 0.005) and different from groups 1 and 3, but the difference between Groups 1 and 3 was not significant. The values are depicted in Table 1. The differences of means of the liver enzymes between the groups (controls, group 2, and group 3) were statistically significant (P < 0.05). On comparison, it was found that the mean values of AST and ALP were not significantly different from those of group 3. The values are depicted in Table 2. Pearsons correlation showed that erythrocyte GSH and plasma ascorbic acid correlated negatively with all the liver enzymes and it was highly significant (P < 0.005) in both alcoholic hepatitis and hepatitis B cases as depicted in Table 3. Erythrocyte MDA also correlated positively with liver enzymes and was also significant (P < 0.005) in both the groups 2 and 3 as depicted in Table 3.
Table 1

Mean values and S.D of Erythrocyte (GSH), (MDA) and Plasma Ascorbic Acid in groups 1, 2 and 3. Comparison of Oxidative stress parameters in group1 (Control), group 2 (Alcoholic Hepatitis) and group 3 (Hepatitis B)

Table 2

Mean values and SD of AST, ALT, ALP and GGT in Groups 1, 2 and 3

Table 3

Correlation between the oxidative stress parameters and liver enzymes

Mean values and S.D of Erythrocyte (GSH), (MDA) and Plasma Ascorbic Acid in groups 1, 2 and 3. Comparison of Oxidative stress parameters in group1 (Control), group 2 (Alcoholic Hepatitis) and group 3 (Hepatitis B) Mean values and SD of AST, ALT, ALP and GGT in Groups 1, 2 and 3 Correlation between the oxidative stress parameters and liver enzymes Increased levels of reactive oxygen species and toxic degradation products have been reported in patients with liver disease. The present study revealed that the patients suffering from liver disease either due to biological agent (hepatitis B virus infection) or chemical agent (excessive alcohol intake) showed significant depletion (P < 0.005) of GSH level when compared with controls, which is in agreement with other studies.[7] Several factors contribute to the fall in GSH level. Most important is oxidative stress, which consumes GSH. Depletion of GSH renders the cell more susceptible to oxidative stress.[8] Decreased GSH reductase activity may be predominant cause of GSH depletion within red blood cell (RBC) leading to serious consequences like increased lipid peroxidation and hemolysis. The other reasons for GSH depletion being, it acts as a co-factor for glutathione transferase (GST) during detoxification of xenobiotics including alcohol and also suppression of glutathione synthesis by ethanol.[910] However, when compared between groups 2 and 3, the mean values of GSH showed no significance (P > 0.05). The present study revealed a significant rise in the MDA levels (P < 0.005) in both groups 2 and 3 patients compared with controls. Raised MDA level reflects the oxidative injury to the liver. Free radical formation that subtracts hydrogen atoms from lipoproteins causing lipid peroxidation, which leads to elevated MDA levels. However, the levels of MDA did not vary significantly (P > 0.05) when compared in groups 2 and 3 cases. It has been found that the ascorbic acid levels were significantly lowered (P < 0.005) in alcoholic patients compared with controls, but the levels were insignificantly reduced (P > 0.05) in case of hepatitis B virus infection. These results corroborated well with previous studies.[710] However, a comparison of the ascorbic acid levels in groups 2 and 3, showed high significance (P < 0.005). The possible explanation for this is that apart from the free radicals mediated depletion of ascorbic acid in hepatitis; alcohol directly reduces ascorbic acid levels in blood by impairing its absorption, disabling transport into the blood, and altering vitamin C metabolism and utilization.[11-13] The measure of liver enzymes revealed a significant rise in the levels of AST (P < 0.005), ALT (P < 0.005), ALP (P < 0.005) and GGT (P < 0.005) in both hepatitis B virus infection and alcoholic hepatitis, compared with controls, which also confirms the literature evidence.[14-16] The AST/ALT ratio was found to be < 1 in controls as well in hepatitis B, but > 1 in alcoholic hepatitis patients. This is due to release of mitochondrial AST by alcohol itself or through its toxicity by its metabolites and/or oxidative stress.[17] Whereas in case of hepatitis B, ALT is typically higher than AST because of slower clearance.[3] Thus the present study revealed a certain degree of oxidative stress and free radicals mediated damage in both alcoholic hepatitis and hepatitis B virus infection. Previous study by Di Sario et al. revealed that liver fibrosis may be considered as a dynamic and integrated cellular response to chronic liver injury. The activation of hepatic stellate cells and the consequent deposition of large amounts of extracellular matrix play a major role in the fibrogenic process, but it has been shown that other cellular components of the liver are also involved. Although the pathogenesis of the liver damage usually depends on the underlying disease, oxidative damage of biologically relevant molecules might represent a common link between different forms of chronic liver injury and hepatic fibrosis. In fact, oxidative stress-related molecules may act as mediators able to modulate all the events involved in the progression of liver fibrosis. In addition, chronic liver diseases are often associated with decreased antioxidant defenses.[18] Earlier authors like Cederbaum and Mormone et al. postulated in their study that chronic HBV infection and long-term consumption of alcohol induce cell damage through increased generation of ROS. Indeed, oxidative stress, which favors mitochondrial permeability transition, is able to promote hepatocyte necrosis and/or apoptosis. In some clinically relevant conditions, generation of ROS within hepatocytes may represent an altered metabolic state as in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, or significant ethanol metabolism as it occurs in alcoholic steatohepatitis. ROS are generated mainly via the mitochondrial electron transport chain via activation of cytochrome P450-mostly cytochrome P450 2E1-, NADPH oxidase, xanthine oxidase, or via mitochondrial damage. The ROS generated can directly affect the hepatic stellate cells and myofibroblasts behavior. ROS up-regulate the expression of critical fibrosis associated gene such as COL1A1, COL1A2, MCP1, and TIMP1 via activation of signal transduction pathways and transcription factors, including Jun Kinase JNK, activator protein-1, and NFκB. ROS generation in hepatic stellate cells and myofibroblasts occur in response to several unknown pro-fibrogenic mediators, including angiotensinII, Platelet derived growth factor, PDGF, TGFβ, and leptin. Overall a decrease in the antioxidant defense such as GSH, catalase or Superoxide dismutase, SOD, in conjunction with enhanced lipid peroxidation leads to a pro-fibrogenic response by enhancing collagen I protein expression.[1920] Thus hepatic ethanol overload is followed both by an increase in reactive oxygen species and by a decline of antioxidants. Obviously the latter can further deteriorate once lipid peroxidation has been stimulated. Previous studies have shown that in hepatitis B virus infection, HBx, the X gene product of hepatitis B virus genome, interacts with an outer mitochondrial voltage-dependent anion channel (VDAC3) and this association leads to a decrease in the mitochondrial membrane potential and causes elevation of reactive oxygen species. In chronic hepatitis B and C there is a significant chronic liver injury with subsequent progression to advanced liver fibrosis and in many cases cirrhosis, a condition characterized by distortion of the normal architecture, septae and nodule formation, altered blood flow, portal hypertension, hepatocellular carcinoma, and ultimately liver failure. While hepatitis B virus can be integrated into the host genome leading to changes in genomic function or chromosomal instability, Hepatitis C cannot integrate into the host genome. Various hepatitis C virus (HCV) proteins, including the HCV core protein, the envelope, and nonstructural proteins present oncogenic properties. This study further revealed, in hereditary hemochromatosis, the excessive absorption and accumulation of iron in tissues and liver as ferritin is related to mutations in the HFE (High-iron gene).[21] When compared between oxidative stress parameters and the liver enzymes in both groups of patients, erythrocyte GSH and plasma ascorbic acid correlates negatively and plasma MDA correlates positively with all the liver enzymes in our study. The extent of damage caused due to oxidative stress was similar in both chemically and biologically induced hepatitis patients. This study has several limitations. First, it is a cross-sectional study comprising a small group; therefore the directionality of associations cannot be clearly established. Second, better characterization and stratification of patients were not possible clinically. Third, this study was carried out purely on biochemical parameters and neither histological study nor parameters that could reveal inflammatory status of the patients were studied. Hence largescale clinical trials to establish a relation between oxidative stress parameters and liver diseases is worth undertaking. This study suggests that supplementation of antioxidants, along with other judicious medical intervention may improve the condition of the patients suffering from such diseases.
  14 in total

1.  Determination of blood total, reduced, and oxidized glutathione in pediatric subjects.

Authors:  A Pastore; F Piemonte; M Locatelli; A Lo Russo; L M Gaeta; G Tozzi; G Federici
Journal:  Clin Chem       Date:  2001-08       Impact factor: 8.327

2.  Dose response effect of rutin a dietary antioxidant on alcohol-induced prooxidant and antioxidant imbalance - a histopathologic study.

Authors:  Madhavan Shenbagam; Namasivayam Nalini
Journal:  Fundam Clin Pharmacol       Date:  2010-08-19       Impact factor: 2.748

Review 3.  Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

Authors:  Elisabetta Mormone; Joseph George; Natalia Nieto
Journal:  Chem Biol Interact       Date:  2011-07-22       Impact factor: 5.192

Review 4.  Role of oxygen radicals in DNA damage and cancer incidence.

Authors:  Marian Valko; Mario Izakovic; Milan Mazur; Christopher J Rhodes; Joshua Telser
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

Review 5.  Nutrition and alcoholic liver disease.

Authors:  Charles H Halsted
Journal:  Semin Liver Dis       Date:  2004-08       Impact factor: 6.115

6.  Monitoring oxidative stress in patients with non-alcoholic and alcoholic liver diseases.

Authors:  Subir Kumar Das; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2005-07

7.  Lipid peroxide levels and antioxidant status in alcoholic liver disease.

Authors:  Seema Gupta; Rajesh Pandey; Ranjan Katyal; H K Aggarwal; R P Aggarwal; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  2005-01

Review 8.  Vitamin E in chronic liver diseases and liver fibrosis.

Authors:  Antonio Di Sario; Cinzia Candelaresi; Alessia Omenetti; Antonio Benedetti
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

9.  CYP2E1 Sensitizes the Liver to LPS- and TNF α-Induced Toxicity via Elevated Oxidative and Nitrosative Stress and Activation of ASK-1 and JNK Mitogen-Activated Kinases.

Authors:  Arthur I Cederbaum; Lili Yang; Xiaodong Wang; Defeng Wu
Journal:  Int J Hepatol       Date:  2011-10-18

10.  Glutathione in cancer cell death.

Authors:  Angel L Ortega; Salvador Mena; Jose M Estrela
Journal:  Cancers (Basel)       Date:  2011-03-11       Impact factor: 6.639

View more
  6 in total

1.  Biochemical Evaluation of Patients of Alcoholic Liver Disease and Non-alcoholic Liver Disease.

Authors:  Prasad P Torkadi; I C Apte; A K Bhute
Journal:  Indian J Clin Biochem       Date:  2013-02-16

Review 2.  Hepatitis B and its Relationship With Oxidative Stress.

Authors:  Seyed Moayed Alavian; Alireza Showraki
Journal:  Hepat Mon       Date:  2016-07-17       Impact factor: 0.660

Review 3.  Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2.

Authors:  Sabrina Sales Martinez; Yongjun Huang; Leonardo Acuna; Eduardo Laverde; David Trujillo; Manuel A Barbieri; Javier Tamargo; Adriana Campa; Marianna K Baum
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

4.  Micronutrient intake and the presence of the metabolic syndrome.

Authors:  Soudabe Motamed; Mahmoud Ebrahimi; Mohammad Safarian; Majid Ghayour-Mobarhan; Mohsen Mouhebati; Mahmoudreza Azarpazhouh; Habibollah Esmailie; Abdolreza Norouzi; Gordon Aa Ferns
Journal:  N Am J Med Sci       Date:  2013-06

Review 5.  Oxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging?

Authors:  Mahdi Ghatreh-Samani; Nafiseh Esmaeili; Masoud Soleimani; Majid Asadi-Samani; Keihan Ghatreh-Samani; Hedayatolah Shirzad
Journal:  Cent Eur J Immunol       Date:  2016-01-20       Impact factor: 2.085

Review 6.  'Magnesium'-the master cation-as a drug-possibilities and evidences.

Authors:  Aparna Ann Mathew; Rajitha Panonnummal
Journal:  Biometals       Date:  2021-07-02       Impact factor: 2.949

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.